国产欧美精品一区二区三区,亚洲国产精品视频,精品999久久久久久中文字幕

FDA Approvals Summary - July 2025 FDA Drug Approvals FDA FDA approved several new drugs in July 2025, including treatments for phenylketonuria, chronic hand eczema, hereditary angioedema, EGFR-mutated lung cancer, and relapsed multiple myeloma, offering new hope for patients.
EU Compromises! Trump: No One Knows Tariffs Better Than Me Trump EU USA Market Trend The EU and US signed a controversial trade deal imposing 15% tariffs on EU exports and $750B in energy purchases from the US. Critics call it a one-sided surrender with major economic and political consequences for Europe.
Just In! FDA Officially Announces New CDER Dire?ctor FDA Dr. George Tidmarsh, biotech leader and Horizon Therapeutics founder, named FDA CDER Director. Discover what this means for drug development, regulation, and innovation. Stay updated with Guidechem’s expert insights.
FDA Approvals Summary - June 2025 FDA Drug Approvals FDA Explore FDA-approved new drugs from June 2025, including breakthroughs for hereditary angioedema, lung cancer, RSV, HIV prevention, bladder cancer, and rare diseases.
UK Drug Rebates to Remain Elevated Through 2027 UK The UK government will maintain high drug rebate rates through 2027, with a 31.3% rate in late 2025 despite industry opposition. The move aims to control NHS costs but raises concerns over R&D investment and international competitiveness.
EU Confirms Vision Risk Tied to Semaglutide EMA EU Wegovy Ozempic Semaglutide EU regulators have confirmed a rare risk of vision loss linked to Novo Nordisk’s semaglutide, used in Wegovy and Ozempic. Drug labels will be updated to reflect the potential for NAION, a serious but very rare eye condition.
FDA Roundtable Targets Faster Cell and Gene Therapy Approvals HHS FDA FDA leaders and top scientists met to discuss cutting red tape in cell and gene therapy approvals. The roundtable emphasized faster innovation, global competition, and regulatory reform amid looming budget cuts.
Senate GOP Eyes Medicare Cuts in Push for Budget Bill Approval Trump Senate Republicans consider Medicare cuts targeting waste and fraud to advance a major budget bill passed by the House. The legislation includes Medicaid work requirements and faces strong opposition from healthcare groups.
EU Pharma Reform Faces Industry Pushback Over IP Cuts EU The EU's major pharma regulatory overhaul aims to improve access and competitiveness but faces strong criticism from EFPIA over reduced IP protections, raising concerns about innovation and global industry appeal.
Trump Tax Bill Exempts Orphan Drugs, Targets PBMs White House Trump The House narrowly passes Trump's "One Big Beautiful Bill Act," altering drug pricing rules and targeting PBMs, while the White House unveils the MAHA report to address childhood health and pharma influence.

<Pre12 3 4 5 6 Next >

News Archives

All Categories

Industry News Agricultural News Industrial News Cosmetic News Exhibition News Food News Science News Pharmaceutical News

永久免费毛片_亚洲成人看片_亚洲春色另类_亚洲综合免费视频_最新高清无码专区_午夜影院a

Chemical Policy

HOT Topics